(Q77133255)
Statements
Administration of abciximab during percutaneous coronary intervention reduces both ex vivo platelet thrombus formation and fibrin deposition: implications for a potential anticoagulant effect of abciximab (English)
G Dangas
J J Badimon
B S Coller
J T Fallon
S K Sharma
R M Hayes
P Meraj
J A Ambrose